MFDS
- Status: likely_approved
🇰🇷 Laidlomycin Propionate in South Korea
Laidlomycin Propionate (laidlomycin propionate potassium) regulatory status in South Korea.
Marketing authorisation
Laidlomycin Propionate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Laidlomycin Propionate approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Laidlomycin Propionate in South Korea?
Marketing authorisation holder not available in our data.